GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, FUT7, GLO1, HSD17B3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR, XDH |
12.816 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
12.1533 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DHFR |
11.8918 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, MMP2, MMP9, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
11.3975 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, HSD17B3, KIT, MET, PPARA, PTGES, PTGS2 |
11.2327 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
11.1656 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
11.1488 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1488 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGES, PTGS2 |
10.6809 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
10.4303 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGES, PTGS2 |
10.4097 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGES, PTGS2 |
10.4019 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
10.2741 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, PHF8, PTGS2, TYR, XDH |
10.1876 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AR, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MAP2K1, MMP12, MMP2, MMP9, PIM1, PTGES, PTGS2, RELA, SLC6A4, SRC, TERT, XDH |
9.84436 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, HSD17B1, HSD17B2, HSD17B3 |
9.67264 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FLT3, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
9.32199 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, TERT, TOP2A, XDH |
9.09625 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TOP2A, XDH |
9.07162 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.07162 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GSK3B, HCAR2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
9.04551 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GSK3B, HCAR2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
9.01088 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
8.97271 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
8.74317 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA, PTGES, PTGS2 |
8.66528 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, KIT, MAOA, MET, PPARA, PTGS2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
8.62446 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGES, PTGS2 |
8.60161 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, KIT, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC |
8.59273 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, KIT, PPARA, PTGS2, RELA, SLC6A4, SRC |
8.3594 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CBR1, CDC25B, CDK6, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A4, SRC, TERT, TNKS2, TOP2A, TYR |
8.23192 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGES, PTGS2 |
7.93334 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, PTGS2, RELA, RORC, SLC6A4, SRC, TERT |
7.93334 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.86034 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, TERT, TOP2A, XDH |
7.8169 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GLO1, IDO1, PPARA, PTGES, PTGS2 |
7.81661 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TOP2A |
7.28984 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, KIT, MET, PPARA, PTGES, PTGS2 |
7.17245 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.06381 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.04779 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, PHF8, PPARA, RELA, SRC, TYR |
7.04779 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA6, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR |
7.04779 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
6.89972 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
6.89972 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.89972 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, PTGS2, RELA, RORC, SLC6A4, SRC |
6.87019 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT |
6.55148 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
6.52251 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
6.44261 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.38736 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
6.34816 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, AR, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TERT |
6.33258 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KCNH2, KDR, KIT, MAP2K1, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.32561 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, GSK3B, IDO1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.3223 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.9664 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AR, AXL, CDK6, CYP1B1, ESR1, GSK3B, IGF1R, MMP2, MMP9, PTGS2, RELA, RORC, SLC6A4, SRC |
5.87398 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
5.86921 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
5.85723 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
5.74994 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, HCAR2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.68323 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CYP1B1, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, PTGS2, PTPN1, RELA, SRC, XDH |
5.68323 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.60401 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, HCAR2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.55109 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CDK6, CYP19A1, DHFR, ESR1, F3, FABP4, GSK3B, IDO1, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
5.45286 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD17B2, IDO1, IGF1R, KCNH2, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TYR |
5.42595 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DHFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SLC6A4, SRC |
5.32661 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1, HSD17B3, IDO1 |
5.24327 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AR, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.21383 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
5.18716 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AR, AXL, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, MMP9, PHF8, PIM1, PPARA, PTGS2, RELA, RORC, SRC, TYR |
5.16893 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.16893 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
5.11778 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.07864 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, GSK3B, HCAR2, IGF1R, KCNH2, KDR, KIT, MAP2K1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
5.0664 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, RORC |
5.03021 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, ESR1, FLT3, GSK3B, IGF1R, KIT, MMP2, PTGS2, RELA, SLC6A4, SRC |
4.96866 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1, HSD17B2, HSD17B3 |
4.95022 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.90995 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CACNA1C, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.86473 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, CYP1A1, FABP3, FLT3, HCAR2, KIT, PPARA, PTGS2, RORC, SRC |
4.8279 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AR, AXL, CA2, CACNA1C, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GSK3B, HCAR2, IDO1, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SLC6A4, SRC, TERT, TNKS2, XDH |
4.81463 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.81433 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, IDO1, KIT, MAP2K1, MMP2, MMP9, PTGS2, SLC6A4, SRC, TOP2A |
4.78794 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DHFR, IDO1, MAOA |
4.78689 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.65855 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.64375 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGES, PTGS2 |
4.63935 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.59975 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CDK6, CYP1A1, CYP1B1, DHFR, FABP3, KCNH2, KDR, PTGS2, RELA, SLC6A2, SLC6A4, SRC |
4.58208 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGES, PTGS2, TERT |
4.49126 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HCAR2, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
4.49126 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, CDK6, HCAR2, KDR, PTGS2, SRC, TNKS, TNKS2 |
4.49118 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
4.42537 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, PIM1, SRC |
4.39396 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.32056 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DHFR, HSD17B3, MAOA, TYR |
4.28143 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
4.27795 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.24392 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, KIT, MAP2K1, SRC |
4.23672 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.23372 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, KIT, MAP2K1, PTGS2, SRC |
4.18122 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.15626 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KCNH2, KDR, PTGS2, RELA, SRC |
4.08038 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, GSK3B, KIT, PPARA, RORC, SLC6A4, SRC, TOP2A |
4.05561 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CYP1B1, ESRRB, F3, HCAR2, IDO1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SRC, TERT |
3.95906 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.89492 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1, HSD17B3 |
3.87097 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTGS2, PTPN1, SRC, TNKS, XDH |
3.87097 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DHFR, ESR1, F3, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.77596 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
3.77596 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TYR |
3.72538 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.65338 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, DHFR, ESR1, ESR2, F3, FLT3, GSK3B, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, TNKS, XDH |
3.64963 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
3.60936 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
3.59363 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AR, AXL, CBR1, CDC25B, CDK6, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A |
3.59363 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTGS2, PTPN1, SRC, TNKS, XDH |
3.55491 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
3.55059 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.51843 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
3.4743 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC6A2, SLC6A4, SRC, TERT, TOP2A |
3.46984 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CDK6, CYP1B1, FABP3, IDO1, MAP2K1, PTGES, PTGS2, SLC6A4, TERT, XDH |
3.45697 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.44513 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, AR, FLT3, KDR, KIT, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
3.44513 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MAP2K1, MET, MMP12, PHF8, PPARA, PTGS2, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
3.42717 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1B1, MMP9, PTGS2, RELA, SRC |
3.41318 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.41318 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.41318 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TYR |
3.38752 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.38752 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, RELA, SRC |
3.35643 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.33191 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.33076 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX5, CES1, CYP19A1, CYP1A1, DHFR, HSD17B3, IDO1, PTGES, PTGS2 |
3.3067 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGES, PTGS2, RELA, SRC |
3.30373 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, CDK6, ESR1, FLT3, RELA, RORC, SLC6A4, SRC |
3.29516 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.28846 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.24562 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.24562 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.24562 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.22502 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.22502 |
[BP] GO:0006693 |
None
|
AKR1C3, CES2, PTGES, PTGS2 |
3.22095 |
[BP] GO:0006692 |
None
|
AKR1C3, CES2, PTGES, PTGS2 |
3.22095 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.21652 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.16799 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, CA2, FLT3, PTGS2, RELA, SRC |
3.16453 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, HSD17B3, PTGES, PTGS2 |
3.16453 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
3.15277 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
3.15277 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.14058 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGES, PTGS2, RELA, SRC |
3.12438 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
3.12438 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.11013 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.09643 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.08191 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.08191 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MAP2K1, MET, MMP12, PHF8, PPARA, PTGS2, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
3.07656 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, DHFR, HSD17B3, TYR |
3.07188 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.05817 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, KIT, MAP3K7, PIM1, RELA |
3.04119 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.04119 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, MMP12, PHF8, PPARA, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
3.01285 |
[BP] GO:0030154 |
cell differentiation
|
AKR1C3, ALPL, AR, AXL, CBR1, CDK6, CES1, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MAP2K1, MMP2, MMP9, PTGS2, RORC, TOP2A |
3.0031 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, RELA, SLC6A4, SRC |
2.98455 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1, RELA |
2.97484 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
2.96913 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
2.92427 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HCAR2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.91121 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
2.90994 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.8657 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, ESR1, F3, FABP4, FLT3, GSK3B, IGF1R, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.83648 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AR, AXL, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HCAR2, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2 |
2.82901 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
2.81108 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MAP2K1, MET, MMP12, PHF8, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.80594 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, AR, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.79085 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
2.7789 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.75965 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
2.75957 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.74651 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.74651 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.74651 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.74651 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.74651 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.73831 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.7375 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, RELA, SLC6A4, SRC |
2.7375 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, IGF1R, KIT, MAP2K1, MAP3K7, PTPN1, SRC |
2.73631 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, GSK3B, HCAR2, KCNH2, MMP12, PTGS2, SLC6A4, SRC, TERT |
2.71825 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.71161 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, APEX1, AR, ESR1, FLT3, KIT, RELA, SRC |
2.71161 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.70242 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, CSNK2A1, ESR1, F3, FLT3, GSK3B, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.69917 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.69373 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, KIT, MAP2K1, MAP3K7, PTPN1, SRC |
2.69373 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.68711 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, AR, CDK6, CYP19A1, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
2.68638 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.68172 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, CYP1A1, PTGS2, RELA, SLC6A4, TYR |
2.6741 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, PTGS2, RELA, SLC6A4, TYR |
2.66897 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.66897 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
2.65833 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.63771 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.626 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DHFR, GSK3B, IGF1R, MAP2K1, MAP3K7, MET, PTGS2, PTPN1, TERT, XDH |
2.60081 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.60081 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, SRC, TNKS, TOP2A |
2.5742 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, KIT, MAP2K1, MET, PIM1, SRC, TYR |
2.57222 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PTGS2, RELA, TYR |
2.57118 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, KIT, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TERT, TYR |
2.54993 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
2.549 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.52992 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.52875 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.52008 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, KIT, MAP2K1, MAP3K7, PTPN1, SRC, TNKS |
2.50209 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, F3, FABP4, FLT3, GSK3B, IGF1R, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, XDH |
2.501 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.501 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, RELA, SRC |
2.501 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.49063 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, F3, FABP4, IDO1, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA |
2.48153 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HCAR2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.48153 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, F3, KIT, MET, SRC, XDH |
2.47089 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
2.47089 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, IDO1, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC |
2.46575 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, DHFR, MAOA, SLC6A4 |
2.45487 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.45487 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.45487 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, ESR1, F3, FLT3, GSK3B, KIT, MAP2K1, MAP3K7, PTPN1, SRC, TERT, TNKS, XDH |
2.45409 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.45338 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, PTGS2, RELA, SLC6A4, TYR |
2.43925 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, GSK3B, HCAR2, KCNH2, MAP2K1, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
2.4234 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, KDR, KIT, MAP2K1, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A4, SRC, TERT, TNKS2, XDH |
2.41931 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, DHFR, SLC6A4 |
2.41224 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.41224 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, ESR1, GSK3B, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.39615 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.38992 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.37954 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.37954 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.37954 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.37954 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, KIT, PTGS2, SLC6A4 |
2.37954 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, KIT, PTGS2, SLC6A4 |
2.37954 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F3, KIT, MET, SRC |
2.3695 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.36212 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.34423 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.33361 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, HCAR2, PTGS2, TNKS, TNKS2 |
2.32946 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.32043 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.32043 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, CA2, CDK6, CYP1B1, ESR1, ESRRA, F3, GSK3B, IDO1, KDR, KIT, MAP2K1, PIM1, PTGS2, RELA, SLC6A4, SRC, TERT, XDH |
2.31439 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.29458 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, FLT3, KIT, PTPN1, SRC |
2.27944 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, CYP1A1, MAP2K1, PTGS2, RELA, TERT |
2.27944 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.2695 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.24304 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.23682 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.23565 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.21561 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, PHF8, PIM1, PPARA, PTGS2, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.16985 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, KIT, MAP3K7, RELA |
2.15552 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.15139 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AR, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MAP2K1, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.14753 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
2.14742 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.14011 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, APEX1, AXL, CA2, CA9, CYP1B1, DHFR, GSK3B, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TOP2A |
2.12706 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.12706 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.12706 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.12706 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.12706 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.11988 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, ESR1, F3, FLT3, GSK3B, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, XDH |
2.11856 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, KIT, PTPN1, SRC |
2.11343 |
[BP] GO:0060969 |
None
|
ESR1, PHF8, TERT |
2.11343 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.11343 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.11343 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.11343 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, GSK3B, IDO1, MAOA, SRC, XDH |
2.10945 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, KIT, MAP2K1, MET, MMP12, PHF8, PPARA, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TOP2A |
2.098 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, CYP1A1, PTGS2, RELA, SLC6A4, SRC, TYR |
2.09702 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, ESRRB, F3, IDO1, KDR, KIT, MAP2K1, PIM1, PTGS2, RELA, SRC, TERT |
2.09622 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.09375 |
[BP] GO:2001251 |
None
|
PHF8, SRC, TNKS, TNKS2, TOP2A |
2.07347 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, PHF8 |
2.07267 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.06397 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, MAOA, PTGS2, SLC6A2, SLC6A4 |
2.06249 |
[BP] GO:0045893 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, PHF8, PPARA, RELA, RORC, SRC, TERT, TNKS, TOP2A |
2.06209 |
[BP] GO:1903508 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, PHF8, PPARA, RELA, RORC, SRC, TERT, TNKS, TOP2A |
2.06209 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, RELA, SRC |
2.06192 |
[BP] GO:1902680 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, PHF8, PPARA, RELA, RORC, SRC, TERT, TNKS, TOP2A |
2.06161 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOA, XDH |
2.06161 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.05383 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2C19, MAOA |
2.0311 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.01819 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, MAOA |
2.0165 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CDC25B, CDK6, CYP1A1, MAP2K1, PIM1, TERT, TNKS, TOP2A |
2.01648 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, ESR1, KIT, PTGS2, SLC6A4, SRC |
2.01575 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IGF1R, KIT, MAP2K1, MAP3K7, MET, MMP12, PHF8, PIM1, PPARA, PTGS2, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.01575 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
2.01575 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.01061 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, KIT, MAP2K1, MAP3K7, PTPN1, SRC |
2.00493 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PTGES, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.98833 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.30373 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.24562 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CACNA1C, CBR1, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B3, IDO1, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.82609 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, APEX1, APP, AR, AURKB, CA4, CA5A, CA5B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, PHF8, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.54174 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CES1, CES2, CYP19A1, FLT3, HSD17B3, KDR, MAP2K1, PTGS2, PTPN1, XDH |
2.32268 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX5, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, F3, FLT3, FUT7, GLO1, GSK3B, HCAR2, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP2, PHF8, PIM1, PTGES, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR |
2.21561 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FLT3, HSD17B2, HSD17B3, PTGES, PTGS2, PTPN1 |
2.01061 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
19.0772 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.2426 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
15.8644 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, F3, FLT3, FUT7, GLO1, GSK3B, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KCNH2, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PTGES, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
15.8644 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, PHF8, PTGS2, TYR, XDH |
10.947 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MAP3K7, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
10.8056 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MAP3K7, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
10.535 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.4558 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3375 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PPARA, PTPN1, RORC, TNKS |
10.1876 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
7.81661 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PHF8, PTGS2, TYR |
7.37698 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PHF8, XDH |
7.24614 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, IDO1, PTGS2, SRC |
6.97987 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
6.85458 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, IDO1, PTGS2, SRC |
6.70212 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.34244 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.21906 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.21906 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, HSD17B1, IDO1, PTGES, PTGS2, SRC, XDH |
6.0176 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC, SHBG |
5.89061 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.68323 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HSD17B1, HSD17B2, HSD17B3, XDH |
5.60498 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19 |
4.98819 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.96866 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PPARA, SLC6A4, SRC, TOP2A |
4.81463 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
4.48794 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.2423 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19 |
4.18052 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2, HSD17B3 |
3.7962 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.66859 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.66479 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
3.65932 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.65509 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2, HSD17B3 |
3.60789 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.59363 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, KIT, MAP3K7, MET, MMP9, PTGS2, RELA, SLC6A4, TERT, TOP2A, TYR, XDH |
3.59363 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.54135 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.20762 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2, HSD17B3 |
3.16453 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, F3, GSK3B, KCNH2, KIT, MET, PPARA, PTGS2, PTPN1, RELA, SLC6A4, SRC, TNKS2, TOP2A |
3.16453 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, PPARA, RORC |
3.07561 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2, HSD17B3 |
3.06915 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.04119 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, PPARA, RORC, SHBG |
3.03457 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
3.03457 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MAP2K1, MAP3K7, MET, PPARA, RORC |
2.83648 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, PPARA, RORC |
2.74651 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.74651 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.74651 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.74651 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.50716 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, PPARA, RORC |
2.4752 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, FLT3, KCNH2, KIT, PTGS2, RELA, SLC6A4, TERT, TOP2A, TYR, XDH |
2.44118 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.38992 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.38992 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.37954 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.37954 |
[MF] GO:0047045 |
None
|
AKR1C3, HSD17B3 |
2.37954 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.37954 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, AR, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, RELA, SRC, TERT |
2.3695 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.21164 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APEX1, APP, AR, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SLC6A4, SRC, TERT, TOP2A, XDH |
2.18132 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.12706 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.12706 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.12706 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AR, AXL, FLT3, KCNH2, KIT, PTGS2, RELA, SLC6A4, TERT, TOP2A, TYR, XDH |
2.11343 |